MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, MCRB has $117,618K in assets. $91,119K in debts. $29,834K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
164.58%
Quick Ratio
164.58%
Cash Ratio
154.23%
Debt to Asset Ratio
77.47%
Unit: Thousand (K) dollars
Assets Breakdown
    • Operating lease assets
    • Less accumulated depreciation an...
    • Cash and cash equivalents
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Operating lease liabilities, net...
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
29,834 45,766 47,638 45,379
Accounts receivable due from spn - related party
0 360 426 882
Accounts receivable
233 157 351 -
Prepaid expenses and other current assets
1,770 3,093 3,112 2,424
Total current assets
31,837 49,376 51,527 48,685
Property and equipment, gross
64,248 64,248 64,953 -
Less accumulated depreciation and amortization
57,394 56,613 56,375 -
Property and equipment, net
6,854 7,635 8,578 9,622
Operating lease assets
70,228 72,483 74,669 76,794
Restricted cash
8,668 8,668 8,668 8,668
Other non-current assets
31 31 31 31
Total assets
117,618 138,193 143,473 143,800
Accounts payable
2,338 1,682 1,677 2,200
Accrued expenses and other current liabilities
2,863 3,972 6,382 5,809
Accrued liabilities due to spn - related party
3,278 3,278 4,450 13,453
Operating lease liabilities
10,865 10,390 9,920 9,478
Total current liabilities
19,344 19,322 22,429 30,940
Operating lease liabilities, net of current portion
69,634 72,576 75,333 77,956
Other long-term liabilities
2,141 2,077 2,014 1,954
Total liabilities
91,119 93,975 99,776 110,850
Common stock, 0.001 par value 360,000,000 shares authorized at march 31, 2026 and december 31, 2025 9,592,326 and 9,556,466 shares issued and outstanding at march 31, 2026 and december 31, 2025, respectively
10 10 9 9
Additional paid-in capital
1,018,805 1,016,611 1,000,756 998,213
Accumulated other comprehensive loss
--0 0
Accumulated deficit
-992,316 -972,403 -957,068 -965,272
Total stockholders' equity
26,499 44,218 43,697 32,950
Total liabilities and stockholders' equity
117,618 138,193 143,473 143,800
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$29,834K Prepaid expenses andother current assets$1,770K Accounts receivable$233K Property and equipment,gross$64,248K Operating lease assets$70,228K Total current assets$31,837K Restricted cash$8,668K Property and equipment,net$6,854K Other non-currentassets$31K Less accumulateddepreciation and...$57,394K Total assets$117,618K Total liabilities andstockholders' equity$117,618K Total liabilities$91,119K Total stockholders'equity$26,499K Accumulated deficit-$992,316K Operating leaseliabilities, net of current...$69,634K Total currentliabilities$19,344K Other long-termliabilities$2,141K Additional paid-in capital$1,018,805K Common stock, 0.001 parvalue 360,000,000...$10K Operating leaseliabilities$10,865K Accrued liabilities dueto spn - related...$3,278K Accrued expenses andother current...$2,863K Accounts payable$2,338K

Seres Therapeutics, Inc. (MCRB)

Seres Therapeutics, Inc. (MCRB)